Arabic Arabic English English French French German German
dark

Pfizer Strengthens Cancer Standing with Protein Degrader Collaboration

This week the pharma giant announced a second collaboration agreement with Connecticut-based Arvinas to develop and commercialize its PROTAC estrogen receptor protein degrader. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Hyperoside ameliorates periodontitis.

Next Post

Beyond telehealth – new data-driven solutions for better care

Related Posts
Total
0
Share